據(jù)美國食品藥品管理局（FDA）消息，2月22日美國FDA發(fā)布關(guān)于亞麻酸（ALA）、二十碳五烯酸（EPA）和二十二碳六烯酸（DHA）Ω-3脂肪酸等多不飽和脂肪酸標(biāo)識要求的小型企業(yè)合規(guī)指南，并自2月23日起征求意見。
2014年4月28日，美國聯(lián)邦公報刊登關(guān)于三種不飽和脂肪酸的營養(yǎng)聲稱標(biāo)識要求，條例于2016年1月1日起生效。條例禁止食品（包含食品補充劑）標(biāo)識聲稱“富含”（及其類似語）DHA或EPA，同時禁止亞麻酸的部分類似聲稱。
部分原文報道如下：
he U.S. Food and Drug Administration is announcing the availability of a Small Entity Compliance Guide （SECG） to help small entities （food companies） comply with FDA's final rule that addressed specific nutrient content claims for Omega-3 fatty acids. The SECG restates the requirements of the final rule in a plain language question and answer format.
The final rule “Food Labeling: Nutrient Content Claims; Alpha-Linolenic Acid, Eicosapentaenoic Acid, and Docosahexaenoic Acid Omega-3 Fatty Acids,” which was published in the Federal Register on April 28, 2014 and became effective January 1, 2016, prohibits claims that a food is “high in” DHA or EPA. Synonyms such as “rich in” and “excellent source of” DHA or EPA are also prohibited. The final rule also prohibits some such claims for ALA, but takes no action with respect to other such claims for ALA.
原文鏈接：http://www.fda.gov/Food/NewsEvents/ConstituentUpdates/ucm484395.htm
日期：2016-02-24
